Department of Pharmaceutical Chemistry

Professor

I am interested in understanding how macromolecular interactions sets up subcellular compartments that control signaling and nuclear domains that regulate gene function. For this goal, I am developing new fluorescence microscopy techniques and engineering new protein and cellular tools, so that the...

Professor

My laboratory is working to understand how cells self-organize into tissues, how the structure of tissues help regulate cell behaviors, and how tissue structure breaks down in diseases like cancer. By understanding these processes we hope to reveal general principles contributing to cancer...

Professor

My lab develops software tool for visualizing and analyzing molecular structures at scales ranging from the atomic to the supramolecular.

Professor

Research in the England Lab is broadly focused on developing and applying chemical probes to investigate the structure and function of signaling proteins implicated in fundamental biological processes and human diseases. Execution of these research projects typically involves a combination of...

Professor

My research focuses on small molecule and protein design as an approach to understanding macromolecule structure and function.

Professor

I focus on defining the roles and the mechanisms of enzymes in complex biological processes and on developing technologies to facilitate these studies to aid in the rapid detection, monitoring, and control of infectious disease and cancer.

Top NIH funding: Shu, Aweeka, Brodsky. Recent gifts to The Kidney Project. Honors and awards: Day, Youmans, Benet, Schoenhaus. New pharmacy care model, Safeway. John Craig remembered. Mary Anne Koda-Kimble celebrated. Achieving our vision: 2007-2012.

Faculty retreat, Recent faculty publications: Burlingame, Arkin, Chen, Cocohoba, Bero. Recently received research funding: Yang, Ahituv, Wells, Burlingame. Gifts: John and Marcia Goldman Foundation: The Kidney Project, Harry W. Hind Request: Troy C. Daniels Distinguished Professorship, The Joseph...

It can take just the flick of a genetic switch for breast cells to kick-start the normally well-regulated process of growth seen in puberty, pregnancy, or the menstrual cycle—or the mutation of that switch to initiate the unchecked proliferation of cancer.

Xiaokun Shu, PhD, has been named a recipient of the 2012 National Institutes of Health (NIH) Director’s New Innovator award, which will provide up to $1.5 million in research funding over the next five